Capital Senior Living (CSU) in Focus: Stock Moves 5.8% Higher
Capital Senior Living Corporation CSU was a big mover last session, as the company saw its shares rise almost 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $13.44 to $14.69 in the past one-month time frame.
The company has seen no estimate revisions over the past few weeks, while the Zacks Consensus Estimate for the current quarter remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Capital Senior Living currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.
Capital Senior Living Corporation Price and Consensus
Capital Senior Living Corporation Price and Consensus | Capital Senior Living Corporation Quote
Another stock worth considering in the Medical sector is Bio-Rad Laboratories, Inc. BIO which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is CSU going up? Or down? Predict to see what others think: Up or Down
Zacks' 2017 IPO Watch List
Before looking into the stocks mentioned above, you may want to get a head start on potential tech IPOs that are popping up on Zacks' radar. Imagine being in the first wave of investors to jump on a company with almost unlimited growth potential? This Special Report gives you the current scoop on 5 that may go public at any time.
One has driven from 0 to a $68 billion valuation in 8 years. Four others are a little less obvious but already show jaw-dropping growth. Download this IPO Watch List today for free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Click for Free Bio-Rad Laboratories, Inc. (BIO) Stock Analysis Report >>
Click for Free Capital Senior Living Corporation (CSU) Stock Analysis Report >>
To read this article on Zacks.com click here.
Zacks Investment Research
